)
)
ReproCELL Incorporated Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from ReproCELL Incorporated
Access all reports
ReproCELL Incorporated is a biotechnology company focused on advancing stem cell research and drug discovery. The company specializes in providing services and products for stem cell research, including iPSC-derived cell lines, media, and other culture reagents. It also offers predictive drug discovery services utilizing human tissues. ReproCELL's offerings support both preclinical and clinical research, with services tailored to meet regulatory standards across various global markets. Its portfolio includes advanced solutions for gene editing, stem cell therapy, and 3D cell culture systems, which cater to a wide range of scientific and medical applications. The company is headquartered in Yokohama, Kanagawa, Japan, and its shares are listed on the Tokyo Stock Exchange.
Latest articles
)
Mercado Libre: The Digital Backbone of Latin America
From shopping to logistics and fintech, Mercado Libre is shaping the digital transformation of Latin America.
3 Jan 2025
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Ticker symbol
4978
Country
🇯🇵 Japan